Back

The predicting system of prognosis for transthyretin amyloid cardiomyopathy

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Chronic heart failure e-posters Biomarkers ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Naoya Nakashima

Kumamoto University Hospital, Kumamoto (Japan)

218 More presentations in this session

Presentation thumbnail
Intermittent therapy with levosimendan in patients with advanced heart failure
Professor M. Weis (Munich, DE)
Abstract Slides
Presentation thumbnail
Differences in long-term all-cause and cardiovascular mortality according to heart failure aetiology in ambulatory patients
Doctor G. Spitaleri (Sant Joan Despi (Barcelona), ES)
Abstract Slides
Presentation thumbnail
Comparing the central arterial stiffness indices in the decompensated and compensated states of heart failure: a cohort study
Assistant Professor G. Youssef (Cairo, EG)
Abstract Slides
Presentation thumbnail
Opportunities for clinician education in the pharmacotherapy of stable heart failure
Doctor P. Murray (Toronto, CA)
Abstract Slides
Presentation thumbnail
Systolic blood pressure visit-to-visit variability and clinical outcomes of heart failure with preserved ejection fraction
Doctor Q. Zhang (Tianjin, CN)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources